The biotechnology company Celcuity Inc. completed a concurrent public offering of $201.3 million of 2.750% convertible senior notes due in 2031 and $97.7 million of common stock and pre-funded warrants. Faegre Drinker represented Celcuity Inc. in the offerings.
.svg?rev=a492cc1069df46bdab38f8cb66573f1c&hash=2617C9FE8A7B0BD1C43269B5D5ED9AE2)
